Baiyunshan: 24 products planned to be selected for continuation of procurement.

Baiyun Mountain Announcement: The holding subsidiary Tianxin Pharmaceutical and the branch Baiyunshan Pharmaceutical Factory's products cefoperazone sodium for injection, clindamycin phosphate for injection, mefloquine hydrochloride tablets, amoxicillin granules, and 24 other products are planned to be selected for this follow-up procurement. The total sales revenue of the above-mentioned selected products in 2024 is RMB 798 million, accounting for 1.06% of the company's 2024 operating income. The total sales revenue for the first three quarters of 2025 is RMB 550 million, accounting for 0.89% of the company's operating income for the first three quarters of 2025.